Instead of focusing on combining current treatments that have off-target effects, inhibition of specific pathways that influence each other, such as DNA repair and PI3k/AKT pathway, may help reduce toxicity and lead to tumour cell death. The gene discussed is AKT1; the disease is neoplasm.